<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE ep-patent-document PUBLIC "-//EPO//EP PATENT DOCUMENT 1.5//EN" "ep-patent-document-v1-5.dtd">
<!-- This XML data has been generated under the supervision of the European Patent Office -->
<ep-patent-document id="EP15715285B8W1" file="EP15715285W1B8.xml" lang="en" country="EP" doc-number="3131927" kind="B8" correction-code="W1" date-publ="20201223" status="c" dtd-version="ep-patent-document-v1-5">
<SDOBI lang="en"><B000><eptags><B001EP>ATBECHDEDKESFRGBGRITLILUNLSEMCPTIESILTLVFIROMKCYALTRBGCZEEHUPLSK..HRIS..MTNORS..SM..................</B001EP><B003EP>*</B003EP><B005EP>J</B005EP><B007EP>BDM Ver 1.7.2 (20 November 2019) -  2999001/0</B007EP></eptags></B000><B100><B110>3131927</B110><B120><B121>CORRECTED EUROPEAN PATENT SPECIFICATION</B121></B120><B130>B8</B130><B132EP>B1</B132EP><B140><date>20201223</date></B140><B150><B151>W1</B151><B153>73</B153><B155><B1551>de</B1551><B1552>Bibliographie</B1552><B1551>en</B1551><B1552>Bibliography</B1552><B1551>fr</B1551><B1552>Bibliographie</B1552></B155></B150><B190>EP</B190></B100><B200><B210>15715285.1</B210><B220><date>20150413</date></B220><B240><B241><date>20161108</date></B241><B242><date>20180608</date></B242></B240><B250>en</B250><B251EP>en</B251EP><B260>en</B260></B200><B300><B310>201470212</B310><B320><date>20140414</date></B320><B330><ctry>DK</ctry></B330></B300><B400><B405><date>20201223</date><bnum>202052</bnum></B405><B430><date>20170222</date><bnum>201708</bnum></B430><B450><date>20201021</date><bnum>202043</bnum></B450><B452EP><date>20200915</date></B452EP><B480><date>20201223</date><bnum>202052</bnum></B480></B400><B500><B510EP><classification-ipcr sequence="1"><text>C07K  16/28        20060101AFI20151026BHEP        </text></classification-ipcr><classification-ipcr sequence="2"><text>C07K  16/46        20060101ALI20151026BHEP        </text></classification-ipcr></B510EP><B540><B541>de</B541><B542>BCMA (CD269) -SPEZIFISCHE CHIMÄRE ANTIGENREZEPTOREN FÜR KREBSIMMUNTHERAPIE</B542><B541>en</B541><B542>BCMA (CD269) SPECIFIC CHIMERIC ANTIGEN RECEPTORS FOR CANCER IMMUNOTHERAPY</B542><B541>fr</B541><B542>RÉCEPTEURS ANTIGÉNIQUES CHIMÉRIQUES SPÉCIFIQUES DE BCMA (CD269), UTILES DANS L'IMMUNOTHÉRAPIE DU CANCER</B542></B540><B560><B561><text>WO-A1-2012/079000</text></B561><B561><text>WO-A1-2013/072406</text></B561><B561><text>WO-A1-2013/154760</text></B561><B562><text>GARFALL ALFRED L ET AL: "Immunotherapy with chimeric antigen receptors for multiple myeloma.", DISCOVERY MEDICINE JAN 2014, vol. 17, no. 91, January 2014 (2014-01), pages 37-46, XP009181586, ISSN: 1944-7930</text></B562><B562><text>CARPENTER R O ET AL: "B-cell Maturation Antigen Is a Promising Target for Adoptive T-cell Therapy of Multiple Myeloma", CLINICAL CANCER RESEARCH, THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, US, vol. 19, no. 8, 15 April 2013 (2013-04-15) , pages 2048-2060, XP002727959, ISSN: 1078-0432, DOI: 10.1158/1078-0432.CCR-12-2422 [retrieved on 2013-01-23]</text></B562><B562><text>FINNEY HELENE M ET AL: "Activation of resting human primary T cells with chimeric receptors: Costimulation from CD28, inducible costimulator, CD134, and CD137 in series with signals from the TCRzeta chain", THE JOURNAL OF IMMUNOLOGY, THE AMERICAN ASSOCIATION OF IMMUNOLOGISTS, US, vol. 172, no. 1, 1 January 2004 (2004-01-01), pages 104-113, XP002420497, ISSN: 0022-1767</text></B562><B562><text>JENSEN MICHAEL C ET AL: "Design and implementation of adoptive therapy with chimeric antigen receptor-modified T cells", IMMUNOLOGICAL REVIEWS, vol. 257, no. 1, Sp. Iss. SI, January 2014 (2014-01), pages 127-144, XP055156740,</text></B562><B562><text>DAVID L PORTER ET AL: "Chimeric Antigen Receptor Therapy for B-cell Malignancies", JOURNAL OF CANCER, vol. 2042127, 1 January 2011 (2011-01-01), page 331, XP055118200, ISSN: 1837-9664, DOI: 10.7150/jca.2.331</text></B562></B560></B500><B700><B720><B721><snm>GALETTO, Roman</snm><adr><str>12 Rue Ernest Cresson</str><city>F-75014 Paris</city><ctry>FR</ctry></adr></B721></B720><B730><B731><snm>Cellectis</snm><iid>101284761</iid><irf>P81403222EP00</irf><adr><str>8, rue de la Croix Jarry</str><city>75013 Paris</city><ctry>FR</ctry></adr></B731></B730><B740><B741><snm>Zacco Denmark A/S</snm><iid>101463545</iid><adr><str>Arne Jacobsens Allé 15</str><city>2300 Copenhagen S</city><ctry>DK</ctry></adr></B741></B740></B700><B800><B840><ctry>AL</ctry><ctry>AT</ctry><ctry>BE</ctry><ctry>BG</ctry><ctry>CH</ctry><ctry>CY</ctry><ctry>CZ</ctry><ctry>DE</ctry><ctry>DK</ctry><ctry>EE</ctry><ctry>ES</ctry><ctry>FI</ctry><ctry>FR</ctry><ctry>GB</ctry><ctry>GR</ctry><ctry>HR</ctry><ctry>HU</ctry><ctry>IE</ctry><ctry>IS</ctry><ctry>IT</ctry><ctry>LI</ctry><ctry>LT</ctry><ctry>LU</ctry><ctry>LV</ctry><ctry>MC</ctry><ctry>MK</ctry><ctry>MT</ctry><ctry>NL</ctry><ctry>NO</ctry><ctry>PL</ctry><ctry>PT</ctry><ctry>RO</ctry><ctry>RS</ctry><ctry>SE</ctry><ctry>SI</ctry><ctry>SK</ctry><ctry>SM</ctry><ctry>TR</ctry></B840><B860><B861><dnum><anum>EP2015057995</anum></dnum><date>20150413</date></B861><B862>en</B862></B860><B870><B871><dnum><pnum>WO2015158671</pnum></dnum><date>20151022</date><bnum>201542</bnum></B871></B870></B800></SDOBI>
</ep-patent-document>
